The prevalence of this deficiency is reported to be approximately 3%, however, people who are severely affected by this deficiency are likely to display neurological symptoms, e.g
View Study Jorizzo J, et al
Expected launch price: $1,400$1,600 per month
For example, Ipamorelin appears to work by potentially binding to the GHS-R1a receptor, also known as the growth hormone secretagogue receptor type 1a, which is found in the pituitary gland and the hypothalamus
It is always recommended to consult healthcare providers before starting any new supplementation regimen, as they can provide guidance based on individual health needs and conditions
Its introduction into clinical practice offers a new horizon for improving metabolic outcomes in patients, with a favorable impact on CV risk factors